ELDORADO ANRS0392s
To evaluate the non-inferiority of doravirine+TDF+3TC compared with dolutegravir+TDF+XTC in terms of virologic efficacy at week 48, as measured by the proportion of subjects achieving a viral load <50 copies/mL, in treatment-naive subjects infected with HIV-1 who had a pretreatment viral load of ≥ 1,000 copies/mL.
Project Details
Principal Investigator
- Prof. Beatriz GRINSZTEJN (Brazil), Dr. Pierre SELLIER (France)
Chef de Projet
- Anthony L.
Participating Countries
- • Brazil
- • Cameroon
- • Ivory Coast
- • France
- • Mozambique
- • Thailand
Duration
48 months
Sponsor
ANRS|MIE
Study start
01 Jan 2025
Objectives
Main Objectives
Research Team
The research team has not yet been filled in for this project.
Collaborate with us
We are open to partnerships with international research institutions and doctoral students.
Estimated response time: 3-5 business days.
